Tags

Type your tag names separated by a space and hit enter

Transobturator tape (TOT): Two years follow-up.
Neurourol Urodyn. 2007; 26(1):37-41.NU

Abstract

AIMS

The aim of this study is to report the functional results, patient satisfaction, and morbidity of the Transobturator tape procedure (TOT) in the treatment of stress incontinence (SUI).

METHODS

One hundred and thirty patients were prospectively evaluated with history, physical examination, quality of life questionnaire including Incontinence Impact Questionnaire (IIQ), urogenital distress inventory (UDI), and analog global satisfaction scale (GSS), and urodynamic studies.

RESULTS

One hundred and seventeen patients (90%) had history of SUI, and 78 (60%) had urge incontinence. Pads/day (PPD) used was 2.48 +/- 2.42, and the score of IIQ 16.13 +/- 7.86, UDI 10.95 +/- 3.4, and GSS 1.41 +/- 1.67. All patients underwent TOT using the ObTape. Hospital stay was 0.84 +/- 0.76 days and catheter duration was 1.42 +/- 2.08 days. At a follow-up of 16.85 +/- 4.68 months, 13 patients (10%) have recurrent SUI, 21 (16.15%) persistent urge incontinence, and 1 (1.92%) de novo urge incontinence. The mean PPD is 0.15 +/- 0.56, IIQ 1.47 +/- 5.14, UDI 3.28 +/- 3.09, and GSS 8.29 +/- 1.64. Two patients (1.52%) developed urethral obstruction, five (3.84%) had vaginal extrusion of the tape, and two (1.52%) had intra-operative bladder perforation.

CONCLUSIONS

These results demonstrate the safety and efficacy of the TOT. The short hospitalization and catheterization, low incidence of de novo urge incontinence and obstructive voiding offers a distinct advantage over existing techniques. No significant difference in outcome between patients with VLPP < or =60 cm H2O, and patients with VLPP >60 cm H2O was observed.

Authors+Show Affiliations

Juma S
Incontinence Research Institute, Encinitas, California 92024, USA. urodawk@aol.com
Brito CG
No affiliation info available

MeSH

AdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansIncidenceLength of StayMiddle AgedMorbidityPatient SatisfactionPostoperative ComplicationsProspective StudiesQuality of LifeRecurrenceSuburethral SlingsSurveys and QuestionnairesTreatment OutcomeUrethral ObstructionUrinary Incontinence, Stress

Pub Type(s)

Clinical Trial
Journal Article

Language

eng

PubMed ID

17083100

Citation

Juma, Saad, and C Gilberto Brito. "Transobturator Tape (TOT): Two Years Follow-up." Neurourology and Urodynamics, vol. 26, no. 1, 2007, pp. 37-41.
Juma S, Brito CG. Transobturator tape (TOT): Two years follow-up. Neurourol Urodyn. 2007;26(1):37-41.
Juma, S., & Brito, C. G. (2007). Transobturator tape (TOT): Two years follow-up. Neurourology and Urodynamics, 26(1), 37-41.
Juma S, Brito CG. Transobturator Tape (TOT): Two Years Follow-up. Neurourol Urodyn. 2007;26(1):37-41. PubMed PMID: 17083100.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Transobturator tape (TOT): Two years follow-up. AU - Juma,Saad, AU - Brito,C Gilberto, PY - 2006/11/4/pubmed PY - 2007/3/28/medline PY - 2006/11/4/entrez SP - 37 EP - 41 JF - Neurourology and urodynamics JO - Neurourol Urodyn VL - 26 IS - 1 N2 - AIMS: The aim of this study is to report the functional results, patient satisfaction, and morbidity of the Transobturator tape procedure (TOT) in the treatment of stress incontinence (SUI). METHODS: One hundred and thirty patients were prospectively evaluated with history, physical examination, quality of life questionnaire including Incontinence Impact Questionnaire (IIQ), urogenital distress inventory (UDI), and analog global satisfaction scale (GSS), and urodynamic studies. RESULTS: One hundred and seventeen patients (90%) had history of SUI, and 78 (60%) had urge incontinence. Pads/day (PPD) used was 2.48 +/- 2.42, and the score of IIQ 16.13 +/- 7.86, UDI 10.95 +/- 3.4, and GSS 1.41 +/- 1.67. All patients underwent TOT using the ObTape. Hospital stay was 0.84 +/- 0.76 days and catheter duration was 1.42 +/- 2.08 days. At a follow-up of 16.85 +/- 4.68 months, 13 patients (10%) have recurrent SUI, 21 (16.15%) persistent urge incontinence, and 1 (1.92%) de novo urge incontinence. The mean PPD is 0.15 +/- 0.56, IIQ 1.47 +/- 5.14, UDI 3.28 +/- 3.09, and GSS 8.29 +/- 1.64. Two patients (1.52%) developed urethral obstruction, five (3.84%) had vaginal extrusion of the tape, and two (1.52%) had intra-operative bladder perforation. CONCLUSIONS: These results demonstrate the safety and efficacy of the TOT. The short hospitalization and catheterization, low incidence of de novo urge incontinence and obstructive voiding offers a distinct advantage over existing techniques. No significant difference in outcome between patients with VLPP < or =60 cm H2O, and patients with VLPP >60 cm H2O was observed. SN - 0733-2467 UR - https://www.unboundmedicine.com/medline/citation/17083100/Transobturator_tape__TOT_:_Two_years_follow_up_ L2 - https://doi.org/10.1002/nau.20353 DB - PRIME DP - Unbound Medicine ER -